Level Biotechnology Cash Flow Reinvestment Rate
Level Biotechnology cash flow reinvestment rate. Level Biotechnology (3118) has a Cash Flow Reinvestment Rate of 0.80x as of September 2025, reinvesting NT$9.45 Million (capex NT$4.44 Million plus investments NT$-5.01 Million) from operating cash flow of NT$11.81 Million. Explore 3118 operating cash flow to total debt to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Level Biotechnology (2017–2024)
Cash flow reinvestment rate of Level Biotechnology from 2017 to 2024. Historical reinvestment intensity for Level Biotechnology across 8 annual periods. Explore 3118 capex reinvestment rate to see what proportion of operating cash flow is directed to capital expenditures.
Level Biotechnology Cash Flow Reinvestment Rate by Year (2017–2024)
Level Biotechnology cash flow reinvestment rate by year from 2017 to 2024. Year-by-year capital reinvestment analysis for Level Biotechnology. For the full cash flow conversion analysis, see Level Biotechnology (3118) cash flow conversion.
| Year | Reinvestment Rate | Total Reinvested (TWD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 3.57x | NT$228.80 Million | NT$64.10 Million | NT$223.68 Million | ▲ +1249.9% |
| 2023 | 0.26x | NT$18.57 Million | NT$70.21 Million | NT$7.67 Million | ▲ +1.7% |
| 2022 | 0.26x | NT$16.93 Million | NT$65.07 Million | NT$6.74 Million | ▲ +317.3% |
| 2021 | 0.06x | NT$9.72 Million | NT$155.95 Million | NT$9.15 Million | ▲ +67.0% |
| 2020 | 0.04x | NT$3.11 Million | NT$83.23 Million | NT$2.54 Million | ▲ +36.0% |
| 2019 | 0.03x | NT$2.99 Million | NT$109.02 Million | NT$2.43 Million | ▼ -76.1% |
| 2018 | 0.11x | NT$3.08 Million | NT$26.77 Million | NT$2.51 Million | ▼ -78.3% |
| 2017 | 0.53x | NT$37.79 Million | NT$71.29 Million | NT$10.83 Million | — |